NCT03818295View on ClinicalTrials.gov

A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

April 24, 2019

Study Completion Date

April 24, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]-praliciguat

10 mg praliciguat containing approximately 500 μCi of \[14C\]-praliciguat

Trial Locations (1)

53704

Covance Clinical Research Unit Inc., Madison

Sponsors
All Listed Sponsors
lead

Cyclerion Therapeutics

INDUSTRY

NCT03818295 - A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter